Followers | 246 |
Posts | 49868 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Saturday, April 20, 2024 12:53:32 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent BVS News
- Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/29/2024 11:30:00 AM
- Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 11:30:00 AM
- Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 09:05:27 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/22/2024 09:07:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 01:27:00 PM
- Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility • GlobeNewswire Inc. • 01/18/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:10:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 09:52:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 09:39:42 PM
- Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole • GlobeNewswire Inc. • 01/12/2024 09:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/09/2024 01:55:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:00:29 PM
- Bioventus Names Robert Claypoole as President and Chief Executive Officer • GlobeNewswire Inc. • 12/19/2023 09:30:00 PM
- Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis • GlobeNewswire Inc. • 12/06/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 12:40:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 12:35:18 PM
- Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance • GlobeNewswire Inc. • 11/07/2023 12:00:00 PM
- Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023 • GlobeNewswire Inc. • 10/31/2023 11:00:00 AM
- Bioventus to Present at the Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/20/2023 01:52:45 AM
- Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference • GlobeNewswire Inc. • 09/06/2023 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 12:42:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:02:41 PM
- Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance • GlobeNewswire Inc. • 08/08/2023 11:30:00 AM
- Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference • GlobeNewswire Inc. • 08/04/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM